This narrative review explores the neurobiological mechanisms underlying hypoactive sexual desire disorder (HSDD) in women, focusing on the inhibitory role of serotonin in sexual desire. The review highlights that serotonin overactivity may contribute to HSDD by suppressing excitatory pathways involved in sexual function. It discusses pharmacologic treatments targeting serotonin, particularly
